Trial Profile
A study investigating the effect of beta amlyoid vaccine (Abeta; AN1792) on neurons in patients with alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Beta-amyloid vaccine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 05 Dec 2015 New trial record